EP3601574A4 - Technische kaskadenkomponenten und kaskadenkomplexe - Google Patents

Technische kaskadenkomponenten und kaskadenkomplexe Download PDF

Info

Publication number
EP3601574A4
EP3601574A4 EP19762697.1A EP19762697A EP3601574A4 EP 3601574 A4 EP3601574 A4 EP 3601574A4 EP 19762697 A EP19762697 A EP 19762697A EP 3601574 A4 EP3601574 A4 EP 3601574A4
Authority
EP
European Patent Office
Prior art keywords
cascade
complexes
modified
components
cascade components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19762697.1A
Other languages
English (en)
French (fr)
Other versions
EP3601574A1 (de
Inventor
designation of the inventor has not yet been filed The
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caribou Biosciences Inc
Original Assignee
Caribou Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/104,875 external-priority patent/US10227576B1/en
Application filed by Caribou Biosciences Inc filed Critical Caribou Biosciences Inc
Priority to EP22208929.4A priority Critical patent/EP4219720A3/de
Publication of EP3601574A1 publication Critical patent/EP3601574A1/de
Publication of EP3601574A4 publication Critical patent/EP3601574A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21004—Type II site-specific deoxyribonuclease (3.1.21.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
EP19762697.1A 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe Withdrawn EP3601574A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP22208929.4A EP4219720A3 (de) 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862684735P 2018-06-13 2018-06-13
US16/104,875 US10227576B1 (en) 2018-06-13 2018-08-17 Engineered cascade components and cascade complexes
US16/262,773 US10329547B1 (en) 2018-06-13 2019-01-30 Engineered cascade components and cascade complexes
US201962807717P 2019-02-19 2019-02-19
US16/420,061 US10457922B1 (en) 2018-06-13 2019-05-22 Engineered cascade components and cascade complexes
PCT/US2019/036864 WO2019241452A1 (en) 2018-06-13 2019-06-12 Engineered cascade components and cascade complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP22208929.4A Division EP4219720A3 (de) 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe

Publications (2)

Publication Number Publication Date
EP3601574A1 EP3601574A1 (de) 2020-02-05
EP3601574A4 true EP3601574A4 (de) 2020-03-18

Family

ID=68843611

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19762697.1A Withdrawn EP3601574A4 (de) 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe
EP22208929.4A Pending EP4219720A3 (de) 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP22208929.4A Pending EP4219720A3 (de) 2018-06-13 2019-06-12 Technische kaskadenkomponenten und kaskadenkomplexe

Country Status (11)

Country Link
EP (2) EP3601574A4 (de)
JP (1) JP6965466B2 (de)
KR (2) KR102516697B1 (de)
CN (2) CN119490976B (de)
AU (2) AU2019284926C1 (de)
CA (2) CA3163768A1 (de)
IL (2) IL278106B2 (de)
MX (2) MX2020013579A (de)
SG (1) SG11202010182SA (de)
WO (1) WO2019241452A1 (de)
ZA (1) ZA202006880B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020257715A1 (en) * 2019-06-21 2020-12-24 The Regents Of The University Of California Crispr-cas3 for making genomic deletions and inducing recombination
CN115003825B (zh) * 2020-01-24 2026-01-13 Ｃ４Ｕ株式会社 检测试样中的特定dna的方法
WO2021183504A1 (en) * 2020-03-11 2021-09-16 North Carolina State University Compositions, methods, and systems for genome editing technology
EP4165178A4 (de) * 2020-06-10 2024-06-19 North Carolina State University Neuartiges typ-i-crispr-cas-system aus clostridia
US12171813B2 (en) 2021-02-05 2024-12-24 Christiana Care Gene Editing Institute, Inc. Methods of and compositions for reducing gene expression and/or activity
CN115369098A (zh) * 2021-05-17 2022-11-22 中国科学院分子植物科学卓越创新中心 一种新型crispr相关转座酶
EP4347818A2 (de) 2021-06-01 2024-04-10 Arbor Biotechnologies, Inc. Geneditierungssysteme mit crispr-nuklease und verwendungen davon
WO2022253277A1 (zh) * 2021-06-03 2022-12-08 中国农业大学 Type I-C CRISPR-Cas3系统及其应用
CN115011581A (zh) * 2022-04-14 2022-09-06 吉林大学 使cas3系统可以精确敲除的方法
CN117384867B (zh) * 2022-09-16 2024-06-07 北京普译生物科技有限公司 一种经修饰的Cas3移位酶及其应用
WO2024077291A2 (en) * 2022-10-07 2024-04-11 The University Of North Carolina At Greensboro Method to generate safer biotechnologies for crispr-based gene editing and therapeutics
WO2024096790A1 (en) * 2022-10-31 2024-05-10 Soledits Ab Modular crispr system
KR20250151430A (ko) 2023-02-15 2025-10-21 아버 바이오테크놀로지스, 인크. 스타스민 2(stmn2) 전사체에서 비정상적인 스플라이싱을 억제하는 유전자 편집 방법
CN121511301A (zh) * 2023-07-26 2026-02-10 Ｃ４Ｕ株式会社 指导rna及其利用
CN116987699B (zh) * 2023-09-05 2024-08-27 深圳市艾迪贝克生物医药有限公司 用于制备通用型car-t细胞的基因片段、其工具系统及应用
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025197847A1 (ja) * 2024-03-18 2025-09-25 国立研究開発法人農業・食品産業技術総合研究機構 改良されたＣＲＩＳＰＲ－Ｃａｓ３システム
WO2026015461A1 (en) * 2024-07-08 2026-01-15 Inari Agriculture Technology, Inc. Type i crispr-cas systems
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026024468A1 (en) 2024-07-26 2026-01-29 Caribou Biosciences, Inc. Modular linked chimeric antigen receptors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013098244A1 (en) * 2011-12-30 2013-07-04 Wageningen Universiteit Modified cascade ribonucleoproteins and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
US7435596B2 (en) 2004-11-04 2008-10-14 St. Jude Children's Research Hospital, Inc. Modified cell line and method for expansion of NK cell
RU2662932C2 (ru) 2013-03-14 2018-07-31 Карибо Биосайенсиз, Инк. Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты
WO2015021426A1 (en) * 2013-08-09 2015-02-12 Sage Labs, Inc. A crispr/cas system-based novel fusion protein and its application in genome editing
JP6712948B2 (ja) * 2013-12-12 2020-06-24 ザ・ブロード・インスティテュート・インコーポレイテッド 組成物、及びヌクレオチドリピート障害におけるｃｒｉｓｐｒ−ｃａｓ系の使用方法
US9650617B2 (en) * 2015-01-28 2017-05-16 Pioneer Hi-Bred International. Inc. CRISPR hybrid DNA/RNA polynucleotides and methods of use
EP4089175A1 (de) * 2015-10-13 2022-11-16 Duke University Genom-engineering mit typ-i-crispr-systemen in eukaryotischen zellen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013098244A1 (en) * 2011-12-30 2013-07-04 Wageningen Universiteit Modified cascade ribonucleoproteins and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOCHSTRASSER MEGAN L ET AL: "DNA Targeting by a Minimal CRISPR RNA-Guided Cascade", MOLECULAR CELL, ELSEVIER, AMSTERDAM, NL, vol. 63, no. 5, 1 September 2016 (2016-09-01), pages 840 - 851, XP029711874, ISSN: 1097-2765, DOI: 10.1016/J.MOLCEL.2016.07.027 *
MAKAROVA KIRA S ET AL: "SnapShot: Class 1 CRISPR-Cas Systems", CELL, ELSEVIER, AMSTERDAM, NL, vol. 168, no. 5, 27 February 2017 (2017-02-27), pages 946, XP029932494, ISSN: 0092-8674, DOI: 10.1016/J.CELL.2017.02.018 *

Also Published As

Publication number Publication date
WO2019241452A1 (en) 2019-12-19
IL314814B1 (en) 2025-08-01
AU2022200903C1 (en) 2025-02-20
CN112272704A (zh) 2021-01-26
JP2021520844A (ja) 2021-08-26
CN119490976B (zh) 2026-03-31
KR102516697B1 (ko) 2023-03-31
EP3601574A1 (de) 2020-02-05
EP4219720A3 (de) 2023-08-30
IL278106A (de) 2020-12-31
CA3163768A1 (en) 2019-12-19
KR20210006966A (ko) 2021-01-19
SG11202010182SA (en) 2020-11-27
ZA202006880B (en) 2021-10-27
AU2019284926C1 (en) 2023-04-27
KR20230035689A (ko) 2023-03-14
AU2022200903B2 (en) 2023-12-21
CN119490976A (zh) 2025-02-21
KR102681113B1 (ko) 2024-07-02
CA3102148A1 (en) 2019-12-19
MX2024010917A (es) 2024-09-17
IL314814A (en) 2024-10-01
IL314814B2 (en) 2025-12-01
AU2022200903A1 (en) 2022-03-03
IL278106B2 (en) 2025-02-01
IL278106B1 (en) 2024-10-01
AU2019284926B2 (en) 2023-01-12
EP4219720A2 (de) 2023-08-02
AU2019284926A1 (en) 2020-11-05
MX2020013579A (es) 2021-05-12
JP6965466B2 (ja) 2021-11-10

Similar Documents

Publication Publication Date Title
EP3601574A4 (de) Technische kaskadenkomponenten und kaskadenkomplexe
IL263730A (en) Binding molecules binding pd-l1 and lag-3
HRP20260186T1 (hr) Inkretinski analozi i njihova upotreba
IL283376A (en) Multivariate and other metal-organic frameworks, and uses thereof
IL262437A (en) Bispecific binding proteins and uses thereof
IL272524A (en) Clec9a binding agents and use thereof
DK3348571T3 (da) Enkeltdomæne-antistof mod programmed death ligand (pd-l1) og deraf afledt protein
SI3443009T1 (sl) Protitelesa proti-TIM-3 in sestavki
EP3349839A4 (de) Hämostaseventile und zugehörige komponenten und verfahren
PL3456346T3 (pl) Cząsteczki wiążące pd-1 i lag-3 oraz sposoby ich zastosowania
EP3633034A4 (de) Modifiziertes cas9-protein und verwendung davon
SI3274370T1 (sl) Protitelesa proti CEACAM6 in njihova uporaba
HRP20260151T1 (hr) Modificirani polipeptidi i njihova uporaba
DK3365368T3 (da) Tgfbeta1-bindende immunoglobuliner og anvendelse deraf
IL253292A (en) Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases
EP3680331A4 (de) Modifiziertes cas9-protein und verwendung davon
DK3265575T3 (da) Cd20-bindende molekyler og anvendelser deraf
DK3535397T3 (da) Alfa-v-beta-6-integrin-ligander og anvendelser deraf
SI3672948T1 (sl) Piridinamin-piridon in spojine pirimidinamin-piridona
EP3717830A4 (de) Konfigurierbare leuchten und komponenten
SI3290441T1 (sl) RGMA-vezavni protein in njegova uporaba
DK3448419T3 (da) Interferon-beta-antistoffer og anvendelser deraf
EP3507592A4 (de) Makrocyclische liganden mit hängenden chelatbildenden gruppen und komplexe davon
MA49905A (fr) Polyesteramines et polyesterquats
EP3848646A4 (de) Kabine und auswurfvorrichtung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190912

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20200217

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101ALI20200211BHEP

Ipc: C12N 15/62 20060101AFI20200211BHEP

Ipc: C12N 9/16 20060101ALI20200211BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: THOMPSON, MATTHEW, SCOTT

Inventor name: GRADIA, SCOTT, DAVID

Inventor name: KLOMPE, SANNE, EVELINE

Inventor name: STERNBERG, SAMUEL, HENRY

Inventor name: CAMERON, PETER, SEAN

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40016587

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201203

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

INTG Intention to grant announced

Effective date: 20240516

INTC Intention to grant announced (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240808

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_47104/2024

Effective date: 20240814

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20241210